Rosario Moratalla

Cajal Institute, CSIC, Madrid 
Parkinson disease, drug abuse, dyskinesia
"Rosario Moratalla"
Mean distance: 13.06 (cluster 6)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Enriquez-Traba J, Yarur-Castillo HE, Flores RJ, et al. (2023) Dissociable control of motivation and reinforcement by distinct ventral striatal dopamine receptors. Biorxiv : the Preprint Server For Biology
Andreska T, Lüningschrör P, Wolf D, et al. (2023) DRD1 signaling modulates TrkB turnover and BDNF sensitivity in direct pathway striatal medium spiny neurons. Cell Reports. 42: 112575
Castela I, Casado-Polanco R, Rubio YV, et al. (2022) Selective activation of striatal indirect pathway suppresses levodopa induced-dyskinesias. Neurobiology of Disease. 105930
Klionsky DJ, Abdel-Aziz AK, Abdelfatah S, et al. (2021) Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition). Autophagy. 1-382
Espadas I, Ortiz O, García-Sanz P, et al. (2020) Dopamine D2R is Required for Hippocampal-dependent Memory and Plasticity at the CA3-CA1 Synapse. Cerebral Cortex (New York, N.Y. : 1991)
García-Sanz P, M F G Aerts J, Moratalla R. (2020) The Role of Cholesterol in α-Synuclein and Lewy Body Pathology in GBA1 Parkinson's Disease. Movement Disorders : Official Journal of the Movement Disorder Society
Pérez-Taboada I, Alberquilla S, Martín ED, et al. (2020) Diabetes Causes Dysfunctional Dopamine Neurotransmission Favoring Nigrostriatal Degeneration in Mice. Movement Disorders : Official Journal of the Movement Disorder Society
Suarez LM, Solis O, Sanz-Magro A, et al. (2020) Dopamine D1 Receptors Regulate Spines in Striatal Direct-Pathway and Indirect-Pathway Neurons. Movement Disorders : Official Journal of the Movement Disorder Society
Gómez-Benito M, Granado N, García-Sanz P, et al. (2020) Modeling Parkinson's Disease With the Alpha-Synuclein Protein. Frontiers in Pharmacology. 11: 356
Espadas I, Keifman E, Palomo-Garo C, et al. (2020) Beneficial effects of the phytocannabinoid Δ-THCV in L-DOPA-induced dyskinesia in Parkinson's disease. Neurobiology of Disease. 104892
See more...